| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 16 | 2023 | 38 | 5.390 |
Why?
|
| Genome-Wide Association Study | 12 | 2024 | 226 | 2.050 |
Why?
|
| HLA-DRB1 Chains | 5 | 2023 | 33 | 1.970 |
Why?
|
| African Americans | 13 | 2020 | 350 | 1.830 |
Why?
|
| Genetic Predisposition to Disease | 19 | 2023 | 655 | 1.550 |
Why?
|
| Polymorphism, Single Nucleotide | 17 | 2024 | 537 | 1.400 |
Why?
|
| Gene Frequency | 7 | 2022 | 182 | 1.390 |
Why?
|
| Sjogren's Syndrome | 11 | 2023 | 261 | 1.210 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2018 | 988 | 1.130 |
Why?
|
| Software | 4 | 2021 | 121 | 1.000 |
Why?
|
| Transcriptome | 4 | 2025 | 205 | 0.990 |
Why?
|
| Central Nervous System Diseases | 1 | 2022 | 12 | 0.810 |
Why?
|
| Tuberculosis | 1 | 2022 | 23 | 0.790 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 28 | 0.790 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 47 | 0.730 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 56 | 0.700 |
Why?
|
| Genetics, Population | 3 | 2021 | 72 | 0.700 |
Why?
|
| Guanylate Kinases | 1 | 2020 | 2 | 0.690 |
Why?
|
| Eye Diseases | 1 | 2020 | 31 | 0.670 |
Why?
|
| Humans | 48 | 2025 | 27116 | 0.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 161 | 0.670 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 64 | 0.660 |
Why?
|
| Monocytes | 1 | 2020 | 132 | 0.660 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 440 | 0.610 |
Why?
|
| Alleles | 9 | 2023 | 345 | 0.610 |
Why?
|
| Genetic Loci | 3 | 2013 | 75 | 0.590 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2017 | 11 | 0.560 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 22 | 0.550 |
Why?
|
| Genotype | 7 | 2021 | 443 | 0.540 |
Why?
|
| Case-Control Studies | 10 | 2020 | 705 | 0.530 |
Why?
|
| Linkage Disequilibrium | 7 | 2021 | 107 | 0.530 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2015 | 7 | 0.510 |
Why?
|
| Synovitis | 1 | 2015 | 6 | 0.510 |
Why?
|
| Arthritis | 1 | 2015 | 29 | 0.500 |
Why?
|
| Interleukin-6 | 1 | 2017 | 189 | 0.500 |
Why?
|
| Uveitis | 1 | 2015 | 23 | 0.500 |
Why?
|
| Male | 25 | 2025 | 13019 | 0.440 |
Why?
|
| Haplotypes | 7 | 2018 | 279 | 0.430 |
Why?
|
| Autoantibodies | 6 | 2025 | 472 | 0.430 |
Why?
|
| Female | 25 | 2025 | 14633 | 0.410 |
Why?
|
| Molecular Motor Proteins | 1 | 2011 | 13 | 0.390 |
Why?
|
| Apolipoproteins | 1 | 2011 | 21 | 0.390 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 22 | 0.390 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 41 | 0.380 |
Why?
|
| Lupus Nephritis | 1 | 2011 | 99 | 0.370 |
Why?
|
| Adult | 14 | 2025 | 7490 | 0.360 |
Why?
|
| Gene-Environment Interaction | 2 | 2020 | 12 | 0.340 |
Why?
|
| Middle Aged | 14 | 2025 | 6899 | 0.340 |
Why?
|
| Pedigree | 5 | 2019 | 153 | 0.330 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 481 | 0.330 |
Why?
|
| Quantitative Trait Loci | 3 | 2018 | 53 | 0.320 |
Why?
|
| Salivary Glands, Minor | 2 | 2017 | 21 | 0.290 |
Why?
|
| Mutation | 3 | 2017 | 818 | 0.290 |
Why?
|
| Models, Genetic | 5 | 2021 | 123 | 0.280 |
Why?
|
| Immunity, Innate | 4 | 2018 | 212 | 0.270 |
Why?
|
| Genetic Association Studies | 5 | 2018 | 110 | 0.270 |
Why?
|
| Family | 2 | 2019 | 98 | 0.260 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 277 | 0.260 |
Why?
|
| Cardiac Myosins | 1 | 2025 | 17 | 0.240 |
Why?
|
| Myocarditis | 1 | 2025 | 21 | 0.240 |
Why?
|
| Biomarkers | 4 | 2023 | 738 | 0.240 |
Why?
|
| Heart Ventricles | 1 | 2025 | 133 | 0.230 |
Why?
|
| Prognosis | 3 | 2022 | 763 | 0.230 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 10 | 0.230 |
Why?
|
| Telomere | 1 | 2024 | 32 | 0.230 |
Why?
|
| Myocardium | 1 | 2025 | 179 | 0.220 |
Why?
|
| Disease Progression | 3 | 2020 | 458 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2023 | 15 | 0.210 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 57 | 0.210 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 18 | 0.210 |
Why?
|
| Transcription Factors | 2 | 2018 | 512 | 0.210 |
Why?
|
| Aged | 9 | 2018 | 5221 | 0.210 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 445 | 0.210 |
Why?
|
| Interleukin-17 | 2 | 2023 | 51 | 0.200 |
Why?
|
| Granuloma | 1 | 2022 | 17 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2023 | 60 | 0.200 |
Why?
|
| Antibodies, Antinuclear | 1 | 2023 | 181 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 278 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 122 | 0.180 |
Why?
|
| Clonal Anergy | 1 | 2020 | 11 | 0.180 |
Why?
|
| Organ Specificity | 1 | 2020 | 81 | 0.180 |
Why?
|
| Immunophenotyping | 1 | 2020 | 59 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 75 | 0.180 |
Why?
|
| Autoimmunity | 2 | 2020 | 154 | 0.180 |
Why?
|
| Morbidity | 1 | 2020 | 57 | 0.170 |
Why?
|
| United States | 4 | 2020 | 2060 | 0.170 |
Why?
|
| Cell Movement | 1 | 2020 | 353 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 145 | 0.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 7 | 0.160 |
Why?
|
| Algorithms | 3 | 2017 | 422 | 0.160 |
Why?
|
| Gene Expression | 1 | 2020 | 408 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 37 | 0.150 |
Why?
|
| Periodontitis | 1 | 2018 | 11 | 0.150 |
Why?
|
| Interferon-alpha | 1 | 2018 | 50 | 0.150 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2018 | 18 | 0.150 |
Why?
|
| Models, Biological | 1 | 2020 | 448 | 0.150 |
Why?
|
| DNA | 1 | 2020 | 365 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 92 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 102 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2016 | 133 | 0.150 |
Why?
|
| Chromatin | 1 | 2018 | 74 | 0.150 |
Why?
|
| Indians, North American | 2 | 2020 | 514 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 241 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2018 | 100 | 0.140 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Neutrophils | 1 | 2018 | 179 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2017 | 47 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 988 | 0.140 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 4 | 0.140 |
Why?
|
| Smoking | 2 | 2022 | 465 | 0.140 |
Why?
|
| Autoimmune Diseases | 3 | 2016 | 162 | 0.140 |
Why?
|
| Genetic Drift | 1 | 2017 | 3 | 0.140 |
Why?
|
| Apoptosis | 1 | 2020 | 740 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2018 | 142 | 0.140 |
Why?
|
| Likelihood Functions | 1 | 2017 | 26 | 0.140 |
Why?
|
| Interferon Type I | 1 | 2017 | 55 | 0.140 |
Why?
|
| Phenotype | 4 | 2022 | 667 | 0.140 |
Why?
|
| Interferon-beta | 1 | 2017 | 40 | 0.140 |
Why?
|
| Mice | 4 | 2023 | 4472 | 0.140 |
Why?
|
| Thymus Gland | 1 | 2017 | 53 | 0.140 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 130 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2017 | 93 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 82 | 0.130 |
Why?
|
| Animals | 6 | 2025 | 10078 | 0.130 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 10 | 0.130 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2016 | 11 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 626 | 0.130 |
Why?
|
| Adaptive Immunity | 2 | 2013 | 37 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2017 | 180 | 0.130 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 123 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 243 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 153 | 0.130 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2015 | 2 | 0.130 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2014 | 12 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 13 | 0.120 |
Why?
|
| HLA-DP beta-Chains | 1 | 2014 | 1 | 0.120 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2014 | 14 | 0.120 |
Why?
|
| Osteoarthropathy, Primary Hypertrophic | 1 | 2014 | 1 | 0.120 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 20 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2017 | 398 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2020 | 1379 | 0.110 |
Why?
|
| Organic Anion Transporters | 1 | 2014 | 7 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2016 | 246 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2014 | 42 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 73 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 24 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 76 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 116 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 28 | 0.100 |
Why?
|
| Biopsy | 3 | 2017 | 201 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2012 | 46 | 0.100 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 32 | 0.100 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 9 | 0.100 |
Why?
|
| Egg Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2018 | 862 | 0.100 |
Why?
|
| Apolipoprotein L1 | 1 | 2011 | 10 | 0.100 |
Why?
|
| Disease | 1 | 2012 | 15 | 0.100 |
Why?
|
| Risk Factors | 4 | 2020 | 2030 | 0.100 |
Why?
|
| Fibrosis | 2 | 2025 | 121 | 0.090 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2010 | 19 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 34 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 30 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 952 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 750 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 928 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 245 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2012 | 467 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 365 | 0.070 |
Why?
|
| Cytokines | 2 | 2023 | 440 | 0.070 |
Why?
|
| Genomics | 2 | 2020 | 116 | 0.060 |
Why?
|
| Consensus | 2 | 2017 | 69 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2025 | 24 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2025 | 19 | 0.060 |
Why?
|
| Cross Reactions | 1 | 2025 | 71 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2017 | 285 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 398 | 0.060 |
Why?
|
| Europe | 2 | 2015 | 97 | 0.060 |
Why?
|
| K562 Cells | 1 | 2024 | 20 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2015 | 93 | 0.060 |
Why?
|
| Epitopes | 1 | 2025 | 180 | 0.060 |
Why?
|
| Exome | 2 | 2014 | 29 | 0.060 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 44 | 0.060 |
Why?
|
| Dysbiosis | 1 | 2023 | 15 | 0.050 |
Why?
|
| Vimentin | 1 | 2023 | 26 | 0.050 |
Why?
|
| Estrogens | 1 | 2023 | 56 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2014 | 229 | 0.050 |
Why?
|
| Whole Exome Sequencing | 1 | 2020 | 9 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 28 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 122 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 57 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 105 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2020 | 68 | 0.040 |
Why?
|
| Bleomycin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2018 | 27 | 0.040 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 6 | 0.040 |
Why?
|
| Treponema denticola | 1 | 2018 | 6 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2018 | 33 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 7 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 221 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2018 | 153 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2017 | 94 | 0.040 |
Why?
|
| ROC Curve | 1 | 2017 | 139 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2017 | 44 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 58 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 201 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 55 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 45 | 0.030 |
Why?
|
| Oklahoma | 1 | 2020 | 978 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 2625 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 198 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 230 | 0.030 |
Why?
|
| Trisomy | 1 | 2016 | 18 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 35 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2016 | 16 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2018 | 648 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 76 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 72 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 472 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 37 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 37 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 70 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 489 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 721 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 774 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 152 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 478 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2014 | 17 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2014 | 13 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 95 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 64 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2014 | 41 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Environment | 1 | 2014 | 61 | 0.030 |
Why?
|
| HLA-DR beta-Chains | 1 | 2013 | 2 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 201 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 58 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1405 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 69 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 331 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 42 | 0.030 |
Why?
|
| Asian Americans | 1 | 2012 | 40 | 0.030 |
Why?
|
| Computational Biology | 1 | 2014 | 150 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1496 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 13 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 67 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 133 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 36 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2011 | 24 | 0.020 |
Why?
|
| American Native Continental Ancestry Group | 1 | 2010 | 22 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 573 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1036 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 1940 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2988 | 0.020 |
Why?
|